These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 35169085)
1. [Evolving Exploration of the Pathogenesis of CNS Germ Cell Tumors with Regard to Precision Medicine]. Takami H; Takayanagi S; Tanaka S; Saito N No Shinkei Geka; 2022 Jan; 50(1):39-50. PubMed ID: 35169085 [TBL] [Abstract][Full Text] [Related]
2. 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors. Satomi K; Takami H; Fukushima S; Yamashita S; Matsushita Y; Nakazato Y; Suzuki T; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Yoshimoto K; Tamura K; Maehara T; Sakai K; Sugiyama K; Yokogami K; Takeshima H; Nonaka M; Asai A; Ushijima T; Matsutani M; Nishikawa R; Ichimura K Neuro Oncol; 2022 May; 24(5):834-846. PubMed ID: 34698864 [TBL] [Abstract][Full Text] [Related]
3. PD-L1 and PD-1 expression in pediatric central nervous system germ cell tumors. Woods JK; Lidov HG; Ligon KL; Santagata S; Chi SN; Yeo KK; Alexandrescu S Mod Pathol; 2022 Dec; 35(12):1770-1774. PubMed ID: 36057740 [TBL] [Abstract][Full Text] [Related]
4. Advances in Molecular Profiling and Developing Clinical Trials of CNS Germ Cell Tumors: Present and Future Directions. Takami H Curr Oncol Rep; 2022 Jan; 24(1):105-112. PubMed ID: 35059994 [TBL] [Abstract][Full Text] [Related]
5. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation. Khatua S; Dhall G; O'Neil S; Jubran R; Villablanca JG; Marachelian A; Nastia A; Lavey R; Olch AJ; Gonzalez I; Gilles F; Nelson M; Panigrahy A; McComb G; Krieger M; Fan J; Sposto R; Finlay JL Pediatr Blood Cancer; 2010 Jul; 55(1):42-6. PubMed ID: 20222020 [TBL] [Abstract][Full Text] [Related]
6. Biomarkers for risk-based treatment modifications for CNS germ cell tumors: Updates on biological underpinnings, clinical trials, and future directions. Takami H; Ichimura K Front Oncol; 2022; 12():982608. PubMed ID: 36132131 [TBL] [Abstract][Full Text] [Related]
7. Impact of tumor markers on diagnosis, treatment and prognosis in CNS germ cell tumors: correlations with clinical practice and histopathology. Takami H; Graffeo CS; Perry A; Giannini C; Nakazato Y; Saito N; Matsutani M; Nishikawa R; Daniels DJ; Ichimura K Brain Tumor Pathol; 2023 Apr; 40(2):124-132. PubMed ID: 36995447 [TBL] [Abstract][Full Text] [Related]
8. Distinct patterns of copy number alterations may predict poor outcome in central nervous system germ cell tumors. Takami H; Satomi K; Fukuoka K; Nakamura T; Tanaka S; Mukasa A; Saito N; Suzuki T; Yanagisawa T; Sugiyama K; Kanamori M; Kumabe T; Tominaga T; Tamura K; Maehara T; Nonaka M; Asai A; Yokogami K; Takeshima H; Iuchi T; Kobayashi K; Yoshimoto K; Sakai K; Nakazato Y; Matsutani M; Nagane M; Nishikawa R; Ichimura K Sci Rep; 2023 Sep; 13(1):15760. PubMed ID: 37735187 [TBL] [Abstract][Full Text] [Related]
9. Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy. Ichimura K; Fukushima S; Totoki Y; Matsushita Y; Otsuka A; Tomiyama A; Niwa T; Takami H; Nakamura T; Suzuki T; Fukuoka K; Yanagisawa T; Mishima K; Nakazato Y; Hosoda F; Narita Y; Shibui S; Yoshida A; Mukasa A; Saito N; Kumabe T; Kanamori M; Tominaga T; Kobayashi K; Shimizu S; Nagane M; Iuchi T; Mizoguchi M; Yoshimoto K; Tamura K; Maehara T; Sugiyama K; Nakada M; Sakai K; Kanemura Y; Nonaka M; Asai A; Yokogami K; Takeshima H; Kawahara N; Takayama T; Yao M; Kato M; Nakamura H; Hama N; Sakai R; Ushijima T; Matsutani M; Shibata T; Nishikawa R; Acta Neuropathol; 2016 Jun; 131(6):889-901. PubMed ID: 26956871 [TBL] [Abstract][Full Text] [Related]
10. [Molecular Characteristics and Clinical Significance of Germ Cell Tumors]. Takami H No Shinkei Geka; 2023 Sep; 51(5):892-900. PubMed ID: 37743341 [TBL] [Abstract][Full Text] [Related]
11. Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy. Murray MJ; Bailey S; Heinemann K; Mann J; Göbel UK; Saran F; Hale JP; Calaminus G; Nicholson JC Int J Cancer; 2017 Aug; 141(3):621-635. PubMed ID: 28463397 [TBL] [Abstract][Full Text] [Related]
12. A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours. Murray MJ; Bell E; Raby KL; Rijlaarsdam MA; Gillis AJ; Looijenga LH; Brown H; Destenaves B; Nicholson JC; Coleman N Br J Cancer; 2016 Jan; 114(2):151-62. PubMed ID: 26671749 [TBL] [Abstract][Full Text] [Related]
13. Transcriptome and methylome analysis of CNS germ cell tumor finds its cell-of-origin in embryogenesis and reveals shared similarities with testicular counterparts. Takami H; Elzawahry A; Mamatjan Y; Fukushima S; Fukuoka K; Suzuki T; Yanagisawa T; Matsushita Y; Nakamura T; Satomi K; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Tamura K; Maehara T; Sugiyama K; Yoshimoto K; Sakai K; Nonaka M; Asai A; Yokogami K; Takeshima H; Narita Y; Shibui S; Nakazato Y; Hama N; Totoki Y; Kato M; Shibata T; Nishikawa R; Matsutani M; Ichimura K Neuro Oncol; 2022 Aug; 24(8):1246-1258. PubMed ID: 35137206 [TBL] [Abstract][Full Text] [Related]
14. Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT Consortium. Takami H; Fukuoka K; Fukushima S; Nakamura T; Mukasa A; Saito N; Yanagisawa T; Nakamura H; Sugiyama K; Kanamori M; Tominaga T; Maehara T; Nakada M; Kanemura Y; Asai A; Takeshima H; Hirose Y; Iuchi T; Nagane M; Yoshimoto K; Matsumura A; Kurozumi K; Nakase H; Sakai K; Tokuyama T; Shibui S; Nakazato Y; Narita Y; Nishikawa R; Matsutani M; Ichimura K Neuro Oncol; 2019 Dec; 21(12):1565-1577. PubMed ID: 31420671 [TBL] [Abstract][Full Text] [Related]
15. [The value of CXorf67 and H3K27me3 for diagnosing germ cell tumors in central nervous system]. Liu YF; Hu XM; Du ZG; Wang Y; Tang F; Xiong J Zhonghua Bing Li Xue Za Zhi; 2022 May; 51(5):407-412. PubMed ID: 35511635 [No Abstract] [Full Text] [Related]
16. Primary CNS germ cell tumors: current epidemiology and update on treatment. Thakkar JP; Chew L; Villano JL Med Oncol; 2013 Jun; 30(2):496. PubMed ID: 23436013 [TBL] [Abstract][Full Text] [Related]
17. Advances in genetic abnormalities, epigenetic reprogramming, and immune landscape of intracranial germ cell tumors. Zhang Y; Zhong C; Ke X; Liu J; Ye Z; Lu L; Deng K; Zhu H; Yao Y Acta Neuropathol Commun; 2023 Nov; 11(1):188. PubMed ID: 38012690 [TBL] [Abstract][Full Text] [Related]
18. Multimodality treatment for Central Nervous System Germ Cell Tumors: Disease spectrum and management strategies - A tertiary care center experience from India. Kumar N; Madan R; Dracham CB; Khosla D; Das N; Dey T; Elangovan A; Tripathi M; Gupta K; Ahuja CK; Kapoor R Clin Neurol Neurosurg; 2021 Mar; 202():106481. PubMed ID: 33508649 [TBL] [Abstract][Full Text] [Related]
19. Multi-institutional analysis of central nervous system germ cell tumors in patients with Down syndrome. Harris MK; Graham RT; Cappellano AM; Margol AS; Michaiel G; Crawford JR; Ioakeim-Ioannidou M; Stanek JR; Liu KX; MacDonald SM; Abdelbaki MS Pediatr Blood Cancer; 2022 Oct; 69(10):e29830. PubMed ID: 35686831 [TBL] [Abstract][Full Text] [Related]
20. Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study. Baek HJ; Park HJ; Sung KW; Lee SH; Han JW; Koh KN; Im HJ; Kang HJ; Park KD J Neurooncol; 2013 Sep; 114(3):329-38. PubMed ID: 23824533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]